Aller au contenu principal
2026 article

First report on the epidemiology and clinical features of multiple valvular heart disease in a middle eastern cohort

0Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : sa, gb. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Background Multiple valvular heart disease (MVD), defined as moderate or severe disease affecting ≥2 valves, is underrepresented in international guidelines and its epidemiology in the Middle East is not well characterized. This study aimed to determine the prevalence and clinical characteristics of significant MVD in a large Middle Eastern tertiary care center. Methods We retrospectively reviewed all transthoracic echocardiograms performed at a large tertiary care center from January 1, 2024–December 31, 2024, in adults ≥18 years with Grade I or greater valve disease. From this cohort, we identified and analyzed patients with moderate, moderate-to-severe, or severe disease involving ≥2 valves (MVD) and characterized their clinical and echocardiographic features. Results Of 16,101 patients with Grade I or greater valve disease, 2,955 (18.3%) had moderate or moderate-to-severe or severe disease in ≥1 valve. Among these, tricuspid regurgitation (TR) was the most common lesion (1,458, 49%), followed by mitral regurgitation (MR) (929, 31%) and aortic stenosis (AS) (410, 14%). Of the 2,955 patients, 565 (19%) had MVD. The MVD cohort was predominantly female (57%), with mean age 57 ± 18 years. Left ventricular systolic dysfunction was common, with median ejection fraction of 42.5% (IQR 27.0-55.0%). Rheumatic etiology accounted for 18% of cases with the remaining 78% due to other causes. Concurrent atrial fibrillation occurred in 18%. Two-valve involvement was most frequent (n=505, 89.4%), followed by three-valve (n=53, 9.4%) and four-valve disease (n=7, 1.2%). Mitral and tricuspid valve combinations dominated the MVD phenotypes, with MR-TR being most prevalent (239 patients, 42.3%), followed by MS-TR (54, 9.6%), TR-PR (50, 8.8%), AS-TR (37, 6.5%), AR-MR (28, 5.0%), AS-MS (21, 3.7%), and AS-MR (15, 2.7%). Conclusions This is the first study to characterize MVD prevalence and characteristics in the Middle East, demonstrating that 19% of patients with moderate or greater valve disease have multiple valve involvement. MVD predominantly affected females and is frequently associated with atrial fibrillation. Further clinical characteristics, long-term outcomes and prognostic implications of this MVD cohort are under investigation.For image description, please refer to the figure legend and surrounding text.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
First report on the epidemiology and clinical features of multiple valvular heart disease in a middle eastern cohort
Date Crossref
01/06/2026
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Alfaisal University pays non établi dans la notice
    Université ou école supérieure
  • King Faisal Specialist Hospital & Research Centre pays non établi dans la notice
    Établissement de santé
  • Cardiff University pays non établi dans la notice
    Université ou école supérieure

Alfaisal University, King Faisal Specialist Hospital & Research Centre et Cardiff University.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Cardiac Valve Diseases and TreatmentsCongenital Heart Disease StudiesCardiovascular Function and Risk Factors

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.